Insights

Growth Markets Genomma Lab has an international expansion footprint across Latin America and the US markets, presenting opportunities to cross-sell pharmaceutical and dermo-cosmetic products to a diverse, growing customer base and leverage regional distribution channels.

Portfolio Expansion With a development pipeline of over 250 products annually across medicines and personal care, there is potential to partner on co-development, licensing, or exclusive distribution deals to accelerate market access and diversify revenue streams.

Strategic Partnerships Recent partnerships focused on softgel product development in LATAM suggest openness to collaboration; sales opportunities exist for contract manufacturing, private-labeling, or joint ventures in complementary dosage forms and formats.

Public Market Position As a leading Mexican pharmaceutical firm listed on the Bolsa Mexicana de Valores, Genomma Lab demonstrates credibility and governance that can facilitate investor-backed initiatives, capital-efficient partnerships, and scalable go-to-market programs.

Digital & Data Adoption of multiple analytics and tagging platforms indicates a data-driven approach to marketing and sales; there is potential to deploy analytics-enabled demand generation, account-based strategies, and performance tracking with Genomma Lab for targeted outreach.

Similar companies to Genomma Lab

Genomma Lab Tech Stack

Genomma Lab uses 8 technology products and services including Hotjar, HubSpot Analytics, Linkedin Insight Tag, and more. Explore Genomma Lab's tech stack below.

Media & News

Genomma Lab's Email Address Formats

Genomma Lab uses at least 4 email formats:
Genomma Lab Email FormatsExamplePercentage
First.Last@genommalab.comJohn.Doe@genommalab.com
66%
FLast@genommalab.comJDoe@genommalab.com
18%
First.Middle@genommalab.comJohn.Michael@genommalab.com
15%
First_Last@genommalab.comJohn_Doe@genommalab.com
1%

Frequently Asked Questions

What is Genomma Lab's official website and social media links?

Minus sign iconPlus sign icon
Genomma Lab's official website is genommalab.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Genomma Lab generate?

Minus sign iconPlus sign icon
As of August 2026, Genomma Lab's annual revenue is estimated to be $500M - $1B.

What is Genomma Lab's SIC code and NAICS code?

Minus sign iconPlus sign icon
Genomma Lab's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 31-33 - Manufacturing.

How many employees does Genomma Lab have currently?

Minus sign iconPlus sign icon
As of August 2026, Genomma Lab has approximately 1.7K employees across 3 continents, including North America, South America and Europe. Key team members include Ceo Chief Executive Officer: M. S., Cmo: D. O. P. and Cfo: A. Z. Explore Genomma Lab's employee directory with LeadIQ.

What industry does Genomma Lab belong to?

Minus sign iconPlus sign icon
Genomma Lab operates in the Manufacturing industry.

What technology does Genomma Lab use?

Minus sign iconPlus sign icon
Genomma Lab's tech stack includes Hotjar, HubSpot Analytics, Linkedin Insight Tag, Amazon Web Services, HubSpot Content Hub, Microsoft 365, Cisco and Piwik PRO Core.

What is Genomma Lab's email format?

Minus sign iconPlus sign icon
Genomma Lab's email format typically follows the pattern of First.Last@genommalab.com. Find more Genomma Lab email formats with LeadIQ.

How much funding has Genomma Lab raised to date?

Minus sign iconPlus sign icon
As of August 2026, Genomma Lab has raised $62M in funding. The last funding round occurred on Jun 03, 2025 for $62M.

When was Genomma Lab founded?

Minus sign iconPlus sign icon
Genomma Lab was founded in 1996.
Genomma Lab logo

Genomma Lab

ManufacturingMexico City, Mexico1001-5000 Employees

Genomma Lab is a Mexican manufacturing company headquartered in Mexico City, focused on health-related products that aim to improve quality of life when used appropriately. It describes itself as an expansive network of firms and institutions that research, produce, and market pharmaceutical and dermo-cosmetic products, maintaining high quality and compliance with national norms governing manufacturing, documentation, and analytics. The company has a growing international footprint, expanding its presence across Latin America and into the United States. Its customers include healthcare providers, institutions, and consumers seeking reliable health and personal care solutions, and its offerings address access to quality medicines and daily wellbeing through a broad product portfolio. It maintains a robust development pipeline, with more than 250 products in development annually across medicines and personal care categories. A notable recent development is a strategic partnership with Procaps Group to co-develop, manufacture, and market five softgel products in Latin America, announced in December 2023.

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
31-33 - Manufacturing
Founded
1996
Employees
1001-5000

Section iconFunding & Financials

  • $62M

    Genomma Lab has raised a total of $62M of funding over 2 rounds. Their latest funding round was raised on Jun 03, 2025 in the amount of $62M as a Post IPO Debt.

  • $500M - $1B

    Genomma Lab's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.